Vanguard Personalized Indexing Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22,313	Closed	-$2.58M	–	1657
2023 Q3	$2.58M	Buy	22,313 +607	+3%	+$65.2K	0.08%	252
2023 Q2	$2.23M	Buy	21,706 +261	+1%	+$27.5K	0.07%	285
2023 Q1	$2.34M	Buy	21,445 +141	+0.7%	+$15.6K	0.08%	242
2022 Q4	$2.42M	Buy	21,304 +9,684	+83%	+$804K	0.1%	207
2022 Q3	$719K	Buy	11,620 +5,186	+81%	+$362K	0.03%	630
2022 Q2	$513K	Sell	6,434 -3,791	-37%	-$359K	0.02%	816
2022 Q1	$1.08M	Buy	10,225 +3,837	+60%	+$374K	0.05%	412
2021 Q4	$688K	Buy	6,388 +1,114	+21%	+$122K	0.04%	565
2021 Q3	$578K	Buy	5,274 +63	+1%	+$6.54K	0.05%	444
2021 Q2	$488K	Buy	5,211 +1,287	+33%	+$118K	0.05%	492
2021 Q1	$361K	Buy	+3,924	New	+$331K	0.05%	435

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Personalized Indexing Management's HZNP Position: Q4 2023 in Review

Vanguard Personalized Indexing Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 22,313 shares — an estimated $2.58M sold.

Vanguard Personalized Indexing Management first reported a position in HZNP in Q1 2021 and held it in 11 quarters. The position peaked at $2.58M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Vanguard Personalized Indexing Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 22,313 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.58M.
Vanguard Personalized Indexing Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 11 quarters.
Vanguard Personalized Indexing Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.58M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2023, filed 8 Feb 2024.